Radius Ventures

Total investments

48

Average round size

18M

Portfolio companies

24

Rounds per year

1.78

Lead investments

7

Follow on index

0.50

Exits

17

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInformation TechnologyHealth CareHealth DiagnosticsMedical DeviceMedicalDeveloper PlatformPharmaceuticalTherapeuticsBiopharma

Summary

Radius Ventures appeared to be the VC, which was created in 1997. The venture was found in North America in United States. The leading representative office of defined VC is situated in the New York.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Radius Ventures, startups are often financed by Foundation Medical Partners, Advanced Technology Ventures, DeNovo Ventures. The meaningful sponsors for the fund in investment in the same round are Advanced Technology Ventures, Foundation Medical Partners, Delta Partners. In the next rounds fund is usually obtained by Advanced Technology Ventures, Foundation Medical Partners, Delta Partners.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Biotechnology, Biopharma. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight EndoGastric Solutions, Heartscape Technologies, Inc., Management Health Solutions.

This organization was formed by Dan Lubin, Jordan S. Davis. We also calculated 2 valuable employees in our database.

The increased amount of exits for fund were in 2007. The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Radius Ventures performs on 5 percentage points more the average number of lead investments. The top activity for fund was in 2007. The fund is constantly included in 2-6 deals per year. Speaking about the real fund results, this VC is 3 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from Radius Ventures is 5-10 millions dollars.

Show more

Investments analytics

Analytics

Total investments
48
Lead investments
7
Exits
17
Rounds per year
1.78
Follow on index
0.50
Investments by industry
  • Health Care (36)
  • Medical Device (26)
  • Medical (17)
  • Health Diagnostics (15)
  • Biotechnology (13)
  • Show 22 more
Investments by region
  • United States (46)
  • United Kingdom (2)
Peak activity year
2007
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Avg. valuation at time of investment
43M
Group Appearance index
0.92
Avg. company exit year
10
Avg. multiplicator
1.21
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Eyetel Imaging 29 Jan 2004 Health Care, Medical Device, Biopharma Early Stage Venture 10M United States, Maryland, Columbia
Resolvyx Pharmaceuticals 22 Apr 2008 Biotechnology, Pharmaceutical, Therapeutics Early Stage Venture 25M United States, Massachusetts, Cambridge

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.